Financhill
Back

Aptevo Therapeutics Stock Predictions

Aptevo Therapeutics Stock Forecast

  • Is Aptevo Therapeutics Stock Undervalued?
    The current Aptevo Therapeutics [APVO] share price is $4.84. The Score for APVO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • APVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Aptevo Therapeutics Stock Go Up Next Year?

Data Unavailable

Aptevo Therapeutics Stock Rating

Data Unavailable

Aptevo Therapeutics Stock Price History

Is APVO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aptevotherapeutics.com

52-Week Data

52-Week High:
399.60
52-Week Low:
3.65

Prediction Charts

Market Cap:
2.6M
Price in USD:
4.84
Volume:
55.8K
Beta:
4.52

Technical Analysis

SMA50:
8.69
SMA100:
9.77
SMA200:
30.80
52-Wk Change:
-98.44%

Stock Predictions

  • Is Aptevo Therapeutics stock public?
    Yes, Aptevo Therapeutics is a publicly traded company.
  • What is the Aptevo Therapeutics stock quote today?
    The Aptevo Therapeutics stock price is 4.84 USD today.
  • How to buy Aptevo Therapeutics stock online?
    You can buy Aptevo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 8.86 9.98 10.39 8.85
Dec-6 8.86 9.98 10.39 8.85
Dec-9 9.64 8.73 9.64 8.72
Dec-10 8.86 9.20 9.34 8.50
Dec-11 9.21 10.01 11.18 9.05
Dec-12 11.48 5.63 14.90 5.30
Dec-13 5.76 4.09 5.95 4.08
Dec-16 4.10 3.88 4.61 3.65
Dec-17 3.84 4.20 4.78 3.84
Dec-18 4.28 4.29 4.90 4.21
Dec-19 4.71 4.53 4.71 4.20
Dec-20 4.68 4.36 4.73 4.23
Dec-23 4.46 4.71 4.71 4.29
Dec-24 4.71 4.84 4.97 4.60

Aptevo Therapeutics Earnings

Data Unavailable

Aptevo Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $17.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,536.34 per share, and an increase next year of $71.15 per share.

* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.